Relatient, Inc., an industry top-rated, SaaS-based patient engagement company announced a new partnership with Unlimited Technology Systems, LLC, a key revenue cycle application provider for specialty healthcare whose Oncology-specific workflow tools are the category leader for cancer centers. Through the new agreement, Unlimited Systems customers using its g4 Studio™ revenue cycle management platform can benefit from customized integration with Relatient’s automated patient engagement solutions to reduce no-shows, improve the patient experience, and increase practice productivity.

“For more than fifteen years, we have been connecting Oncologists with the best tech platforms available to run their cancer centers and effectively manage patient data. Today we’re excited to formally extend our integrated solution to include Relatient’s next generation patient engagement platform,” said Brian Gockerman, CEO, Unlimited Systems. “Our customers will benefit from Relatient’s track record of quickly impacting outcomes for patients and providers and enhancing the patient experience and revenue results.”

Relatient’s platform of solutions automates 16 different touch points along the outpatient journey including appointment reminders, surveys, two-way messaging, broadcast messaging, self-scheduling, waitlist outreach, and mobile registration. Built especially for enterprise organizations, Relatient powers patient communication across multiple locations and multiple specialties with 2-way chat, text, email, and voice technology.

“Unlimited Systems has been such a unique company to work with, given their specialty expertise and great relationship with their customers. We’re excited to formalize and expand what we’re doing together,” said Michele Perry, CEO, Relatient. “As a breast cancer survivor, these Oncology practices and their patients are close to my heart. I’ve been there, and I’m honored to join Unlimited Systems in improving the patient experience and provider communications.”

Relatient Patient Engagement Specialists are working closely with Unlimited Systems customers and are available to advise healthcare organizations of their patient engagement options. Contact Relatient to schedule a demo or learn more.    

About Relatient 
Relatient is an industry-recognized and award-winning, SaaS-based patient engagement company that utilizes modern and mobile modalities to improve patient and provider communications. Relatient has engaged more than 25 million patients on behalf of U.S. providers, medical practices, hospitals, and health systems with a projected 120 million delivered messages in 2019. Relatient’s platform integrates with practice management and electronic health databases to drive operational efficiency, appointments and online reviews, reduce no-shows, speed patient payments, and improve patient satisfaction, all while supporting health and care quality initiatives. Visit http://www.relatient.net

About Unlimited Systems 
Unlimited Systems is software development company headquartered in Cincinnati, Ohio for the past sixteen years and focused on financial management solutions for specialty healthcare. More than 3,000 Oncology providers already utilize Unlimited’s software to effectively drive their front office and revenue cycle operations and better support patient care. Unlimited Systems is committed to ensuring that specialty healthcare providers thrive in a dynamic reimbursement environment. The organization takes pride in knowing that their efforts directly impact the lives of cancer patients and the effectiveness of cancer centers across the nation. Learn more at http://www.g4studio.com/

Contact 

James Kanka 
Sr. Director of Marketing Relatient, Inc. 
(615) 208-7384 
jkanka@relatient.net

Make text, email and voice an integral part of your patient engagement.

The post Relatient & Unlimited Systems Partner to Make Patient-Engagement Easier for Oncologists and Cancer Patients appeared first on Relatient.


Source: Relatient & Unlimited Systems Partner to Make Patient-Engagement Easier for Oncologists and Cancer Patients